Dexcom
Manufacturing · California, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
6340 Sequence Dr, San Diego, California,...Phone Number
(844) 607-8398Website
www.dexcom.comRevenue
$4.8 BillionStock Symbol
DXCMIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
13
14
1
2
2
2
About Dexcom
Dexcom, Inc. is a leading medical technology company that develops and manufactures continuous glucose monitoring systems for people with diabetes. Its devices provide realtime glucose data to help users manage their health effectively. The company focuses on innovation, accuracy, and improving quality of life while advancing diabetes care worldwide.Explore more
Dexcom Org Chart
Get the full picture
Sign in to uncover key details.
PL
Senior Director, Intellectual Property & Asso...
KC
General Counsel
ST
IP Senior Director & Associate General Counse...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dexcom your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Dexcom, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Dexcom
Earning: See what the market has to say on Dexcom recently announced quarterly report
Check out if Dexcom is spiking on competitors!
Product Launch: Get notified when Dexcom launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Dexcom had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Dexcom has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Dexcom has new funding data
Recommended Actions
Find VP level buyers at Dexcom
Find more new buyers
Compare Similar Companies to Dexcom
Compare insights from companies similar to Dexcom, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Dexcom is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dexcom is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dexcom.
Dexcom financials insights
Gather financial insights about Dexcom, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2002
Series C
$30M
2005
Series D
$22.5M
Stock Offering
$50.6M
2017
Share Placement
$350M
2020
Series B
$4.6M
Dexcom Tech Stack
A closer look at the technologies used by Dexcom
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Dexcom News & Media
Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels
Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use insulin.Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits ...
Dexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin around the world. Showed use of Dexcom G7 led to clinically and statistically significant reduction in HbA1c and improvement in quality of glucose control, including time in range and level 1 and 2 hyperglycemia.1 Demonstrated additional clinically significant improvement in A1C reduction across study participants using Dexcom G7 inDexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?
DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line. Which strategy stands out?DexCom director receives 5,565-share RSU grant | DXCM Insider Trading - Stock Titan
DexCom director Steven R. Altman reports a grant of 5,565 restricted stock units vesting by the 2027 annual meeting and discloses 63,667 shares held through a family trust.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dexcom
Sign Up For FreeTo access detailed company insights
Dexcom, Inc. is a leading medical technology company that develops and manufactures continuous glucose monitoring systems for people with diabetes. Its devices provide realtime glucose data to help users manage their health effectively. The company focuses on innovation, accuracy, and improving quality of life while advancing diabetes care worldwid... Read More
